S., P., S., Z., WL., C., GR., F., SK., S., R., F., . . . Team., f. t. B. S. (2014). Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.
Chicago Style CitationS., Pianko, et al. Randomized Trial of Albinterferon Alfa-2b Every 4 weeks for Chronic Hepatitis C Virus Genotype 2/3. 2014.
MLA CitationS., Pianko, et al. Randomized Trial of Albinterferon Alfa-2b Every 4 weeks for Chronic Hepatitis C Virus Genotype 2/3. 2014.
Warning: These citations may not always be 100% accurate.